产品说明书

PKUMDL-WQ-2101

Print
Chemical Structure| 304481-72-9 同义名 : -
CAS号 : 304481-72-9
货号 : A1281476
分子式 : C14H11N3O6
纯度 : 99%+
分子量 : 317.254
MDL号 : MFCD00589939
存储条件：

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 120 mg/mL(378.25 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
描述 Phosphoglycerate dehydrogenase (PHGDH) is a key enzyme that catalyzes serine biosynthesis and is involved in metabolic reprogramming in cancer. PKUMDL-WQ-2101 is a selective allosteric inhibitor of PHGDH with an IC50 value of 34.8±3.6μM (max inhibition = 67%). Compared to wide-type PKUMDL-WQ-2101, the PHGDH-inhibiting activities were markedly reduced for mutants R134A (IC50 = 141±4μM, max inhibition = 49%) and K57AT59A (IC50 = 128±10μM, max inhibition = 47%). The antitumor activities of PKUMDL-WQ-2101 in two PHGDH amplified breast cancer cell lines (MDA-MB-468 and HCC70) were 7.70μM and 10.8μM, respectively. The IC50 values of PKUMDL-WQ-2101 for the GFP KO cells was 37.3μM. The inhibition of PHGDH by PKUMDL-WQ-2101 (37μM) decreased de novo serine synthesis and metabolism downstream of the serine synthesis pathway in SKOV3 GFP KO cells. PKUMDL-WQ-2101 treatment at a dose of 20mg/kg/day inhibited the growth of MDA-MB-468 xenografts compared with vehicle-treated mice after 30 days of drug delivery[1].
作用机制 PKUMDL-WQ-2101 is a selective allosteric inhibitor of PHGDH. It inhibits PHGDH activity mainly by forming hydrogen-bond networks with site I[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.15mL

0.63mL

0.32mL

15.76mL

3.15mL

1.58mL

31.52mL

6.30mL

3.15mL
参考文献

[1]Wang Q, Liberti MV, Liu P, Deng X, Liu Y, Locasale JW, Lai L. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity. Cell Chem Biol. 2017 Jan 19;24(1):55-65. doi: 10.1016/j.chembiol.2016.11.013